N-Nitroso Edoxaban Impurity 4
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs .N-Nitroso Edoxaban Impurity 4 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 4 chemically represented as 2-bromo-5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridine . Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 4 .We supply N-Nitroso Edoxaban Impurity 4 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E39273 |
| CAS No | 1276636-37-3 |
| Mol.F. | C14H25NO4 |
| Mol.Wt. | 271.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39274 |
| CAS No | 169044-84-2 |
| Mol.F. | C14H25NO4 |
| Mol.Wt. | 271.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39275 |
| CAS No | 1392745-59-3 |
| Mol.F. | C14H26N2O4 |
| Mol.Wt. | 286.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39276 |
| CAS No | 1210348-23-4 |
| Mol.F. | C14H26N2O4 |
| Mol.Wt. | 286.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39277 |
| CAS No | NA |
| Mol.F. | C14H26N2O4 |
| Mol.Wt. | 286.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39278 |
| CAS No | NA |
| Mol.F. | C30H52N6O8 |
| Mol.Wt. | 624.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39279 |
| CAS No | 365997-35-9 |
| Mol.F. | C14H24N4O4 |
| Mol.Wt. | 312.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39280 |
| CAS No | 365996-07-2 |
| Mol.F. | C6H7BrN2S |
| Mol.Wt. | 219.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39281 |
| CAS No | 97817-23-7 |
| Mol.F. | C6H9N3S |
| Mol.Wt. | 155.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39282 |
| CAS No | 1256793-89-1 |
| Mol.F. | C8H10N2O2S |
| Mol.Wt. | 198.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39283 |
| CAS No | 1135122-10-9 |
| Mol.F. | C9H12N2O2S : HCl |
| Mol.Wt. | 212.3 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39284 |
| CAS No | 1053656-51-1 |
| Mol.F. | C14H20N2O4S |
| Mol.Wt. | 312.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39285 |
| CAS No | 1448536-69-3 |
| Mol.F. | C8H6N2O2S |
| Mol.Wt. | 194.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39286 |
| CAS No | NA |
| Mol.F. | C8H8N2O2S |
| Mol.Wt. | 196.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39287 |
| CAS No | 2250242-53-4 |
| Mol.F. | C9H8Cl2N2O3 |
| Mol.Wt. | 263.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39288 |
| CAS No | NA |
| Mol.F. | C8H10N2O3S |
| Mol.Wt. | 214.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |